Suppr超能文献

数据豁免提供者开具丁丙诺啡处方的障碍和促进因素:应用计划行为理论的定性分析。

Barriers and Facilitators to DATA Waivered Providers Prescribing Buprenorphine: A Qualitative Analysis Applying the Theory of Planned Behavior.

机构信息

Department of Pharmaceutical Health Outcomes and Policy, University of Houston, Houston, Texas, USA.

Arlington School of Social Work, University of Texas at Arlington, Arlington, Texas, USA.

出版信息

Subst Use Misuse. 2022;57(12):1761-1771. doi: 10.1080/10826084.2022.2112226. Epub 2022 Aug 21.

Abstract

Provider beliefs about the treatment of people with addiction may influence their prescribing behavior. This study applied the Theory of Planned Behavior (TPB), to identify the salient beliefs of Drug Addiction Treatment Act of 2000 (DATA 2000) waivered providers, concerning prescribing buprenorphine to patients with Opioid Use Disorder (OUD). Texas buprenorphine providers participated in one of four online focus group discussions conducted in fall 2019. The focus group discussion were audio recorded and the total length was between 60-90 minutes. Thematic analysis was conducted to identify emerging themes and to categorize the behavioral, normative, and control beliefs related to buprenorphine prescribing. Of the 14 total participants, 57% of the participants were male and annually treated between zero to sixty patients with buprenorphine. The codes generated were represented in thematic maps, specifying the positive or negative aspects of buprenorphine prescribing. Results indicate that providers' primary motivation to prescribe buprenorphine was, implementation of a whole-patient approach through collaboration with behavioral health providers, in the provision of medications for opioid use disorder (MOUD). Providers primary normative belief was the recognition of key members of the medical community and patients' families and friends as influential groups. Providers' control beliefs focused on their ability to use buprenorphine in different practice settings. These results indicate that buprenorphine access may be expanded by increasing support for DATA waivered providers from other parts of the healthcare system such as behavioral health providers and pharmacists. Implications for clinical practice and future research will be discussed.

摘要

提供者对成瘾者治疗的信念可能会影响他们的处方行为。本研究应用计划行为理论(TPB),确定 2000 年《药物滥用治疗法》(DATA 2000)豁免提供者对阿片类药物使用障碍(OUD)患者开丁丙诺啡的显著信念。德克萨斯州的丁丙诺啡提供者参加了 2019 年秋季进行的四个在线焦点小组讨论之一。焦点小组讨论被录音,总长度在 60-90 分钟之间。采用主题分析来确定出现的主题,并对与丁丙诺啡处方相关的行为、规范和控制信念进行分类。在 14 名参与者中,57%的参与者为男性,每年治疗零到六十名丁丙诺啡患者。生成的代码以主题图的形式表示,指明了丁丙诺啡处方的积极或消极方面。结果表明,提供者开丁丙诺啡的主要动机是通过与行为健康提供者合作,对阿片类药物使用障碍(MOUD)患者实施整体患者治疗方法。提供者的主要规范信念是认识到医疗社区的关键成员以及患者的家人和朋友是有影响力的群体。提供者的控制信念集中在他们在不同的实践环境中使用丁丙诺啡的能力上。这些结果表明,可以通过增加来自医疗保健系统其他部分(如行为健康提供者和药剂师)对 DATA 豁免提供者的支持,来扩大丁丙诺啡的获取途径。将讨论临床实践和未来研究的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验